Cannabis Stocks Becoming A Trend As Talks of Legalization Continues.

The rampant use of marijuana as a coping method during the COVID-19 pandemic has made entrepreneurs join in on the action. Speculation on the

best cannabis stocks

becomes more apparent. That may be because legal cannabis use is projected to reach over $23 billion by 2022. With price movement still pretty much volatile in the

stock market

, it has created an opportunity for traders and investors alike to flip in the short run.

Interests in cannabis agriculture do not only come from budding. Even greenhouse agriculture giant Village Farms International (

NASDAQ: VFF

) is expanding into the cannabis industry. The company’s acquisition of Pure Sunfarms in Q4 2020 has allowed Village farms to record $47.4 million in sales in the same quarter. The company also achieved a net income of $11.6 million for 2020, a 404% increase compared to the year before.

While cannabis is often known for its euphoric effect, companies like Charlotte’s Web (

OTCMKTS: CWBHF

) are looking to harness its therapeutic side to its fullest. The company recently launched its cannabidiol (CBD) oil tinctures for chronic pain management. This could become a best-seller among frontline workers as they can reap the product benefit without affecting cognition. With such huge potential and market opportunity, let’s take a look at four of the

top cannabis stocks to watch

in March 2021.

Top Cannabis Stocks to Watch In March 2021:

• 
  Tilray Inc.
  
  (
  
  NASDAQ: TLRY
  
  )
• 
  Cresco Labs Inc.
  
  (
  
  OTCMKTS: CRLBF
  
  )
• 
  Innovative Industrial Properties Inc.
  
  (
  
  NYSE: IIPR
  
  )
• 
  GrowGeneration Corp
  
  (
  
  NASDAQ: GRWG
  
  )

Tilray Inc. (TLRY)

Discussion of a merger between Aphria (

NASDAQ: APHA

) and Tilray that will commence on April 16 has created excitement among investors. While the boards of directors of both companies agree to the deal, a special shareholder meeting will occur between the two to vote and finalize the decision. The merging of the two companies is set to create one of the largest global marijuana companies in the market.

Since the announcement of the merger in mid-December, TLRY stock has more than tripled. Separately, news about possible weed legalization in New York has definitely contributed to Tilray’s momentum. With such movements, it is no surprise that many investors are big fans of TLRY stock.

As Tilray is waiting for FDA regulations before moving into the U.S. CBD market, the company has created a significant presence in the European market. Not only does its cultivation in Portugal reduce cost, but this allows Tilray to avoid applied tariffs on imported goods altogether. This creates cost efficiency and expands the company’s profit in the long run. With that said, will you be making a buy on TLRY stock?

Read More

• 
  Should Investors Buy These Top Entertainment Stocks?
  
• 
  Top Stocks To Invest In Right Now? 4 Tech Stocks To Watch
  

Cresco Labs Inc. (CRLBF)

One of the largest cross-state operators in the country, Cresco Labs is a vertically integrated cannabis company. It leads the competition as the largest wholesaler of branded cannabis products. The company has not only acquired a license to operate in Ohio. It will also begin distribution in Arizona. The company is definitely looking to target every state once legislators give a green light for cannabis consumption.

While most cannabis companies find it hard to profit in the U.S. market, it came easy for Cresco Labs. Not only that the company is selling in nine different states, but the company also has established 15 production facilities and over 25 retail outlets nationwide. Such proliferation of business allowed Cresco Labs to achieve high revenue growth.

With CRLBF stock gaining over 130% in the last 6 months, it has certainly been rewarding for investors who have been holding the stock. In the company’s third-quarter 2020 results, it reported over $153 million in revenue. That’s sequentially up by 63% and 323% year over year. The company is expected to release its Q4 financial performance on March 25. Seeing how Cresco Labs consolidated itself as the leading cannabis company in the U.S., will it be enough to make you buy CRLBF stock today?

[Read More]


Looking For Consumer Stocks To Buy This Week? 4 Names To Watch

Innovative Industrial Properties Inc. (IIPR)

Innovative Industrial Properties has made a purchase of a cannabis cultivation farm in Illinois worth $6.5 million. The REIT also secured $45 million in financing to fund building for a facility in said site, which will be leased back to 4Front Ventures Corp. Not only will such a facility create a foothold for the REIT company, but it also stands to create jobs and boost the economy in that state.

Innovative Industrial Properties have also recently declared the company’s first quarter’s dividends in 2021 of $1.32 per share of common stock. This represented an estimate of a 6% gain over IIP’s Q4 dividend performances, with the total cumulative dividend for 2020 reaching $5.28 per common share. Analysts estimate dividend earnings could reach up to $7.30 per share this year with $158 million in revenue.

It’s worth pointing out that the company is essentially a landlord to other cannabis growers and operators. Therefore, IIPR stock may attract investors looking for exposure in cannabis stocks minus the high volatility. With the company’s recent moves, will it be attractive enough for investors to buy more IIPR stock?

[Read More]


Best Fintech Stocks to Buy This Week? 4 Names to Know

GrowGeneration Corp (GRWG)

Lastly, we have GrowGeneration Corp, a cannabis grower, and retailer. The company has been making it on the front page of cannabis stock news with multiple acquisitions in a short time span. By acquiring Char Coir, 55 Hydroponics, and Aquarius Hydroponics under its belt, GrowGen is rapidly expanding its influence across states while merging different levels of production to keep running costs low.

Such acquisition reflected positively among investors, as GRWG stock closed its trading with a jump of 4.6% on Wednesday. Moreover, the company could post quarterly earnings of $0.06 per share in its next quarterly report, versus a loss of $0.01 in the same quarter last year. Revenues for GrowGen are also expected to hit over $61 million, an increase of 140.5% from last year’s quarter.

Even at the peak of the pandemic, GrowGen has been gaining sales momentum in all channels, online commercial and retail. The company also has rebranded its existing e-commerce platform to GrowGen.Pro. This offers an omnichannel approach to facilitate online purchases across all locations. As GrowGen expands its influence across the country, will it be enough to induce a buy in GRWG stock?